Clinical trial Recruiting at 2 sites Observational Ages Any age to 28 Weeks

Monitoring clinical stability in extremely low birth weight infants after extubation

Official title: Post-Extubation Assessment of Clinical Stability in Extremely Preterm Infants: The PEACE Feasibility Study

Run by McGill University Health Centre/Research Institute of the McGill University Health Centre · NCT06037083 · Data updated 2026-11-12

This study is trying out a new monitoring system to see if it can help doctors better track the health of extremely low birth weight infants after they are taken off breathing machines.

Quick facts

Study typeObservational
AgesAny age to 28 Weeks
SexAll
Enrollment20 (estimated)
SponsorMcGill University Health Centre/Research Institute of the McGill University Health Centre
Academic / other
Locations2 sites (Montreal, Quebec and 1 other locations)
StatusRecruiting
StartedOctober 29, 2024
Main results expectedDecember 31, 2026
Study endsApril 2027
Registry record updatedMarch 30, 2026
Trial IDNCT06037083 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are infants with a birth weight less than 1000g and a gestational age of less than 28 weeks who have received mechanical ventilation within the first 72 hours of life.

Probably not a fit

Patients with congenital anomalies or congenital heart disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study evaluates the feasibility of a multimodal monitoring system for extremely low birth weight infants at high risk of reintubation. It integrates clinical data and high-resolution waveforms from bedside monitors, along with regional oxygenation and ventilation measurements. The study will longitudinally assess oxygen saturation and ventilation in these infants during the week following extubation, aiming to improve the accuracy and standardization of clinical stability assessments. By providing a comprehensive view of organ function, the study seeks to inform reintubation decisions and tailor treatment plans.

Why it matters

Potential benefit: If successful, this approach could lead to better outcomes for extremely low birth weight infants by reducing the need for reintubation and improving individualized care.

How similar studies have gone: While this approach is innovative, similar multimodal monitoring strategies have shown promise in other populations, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Birth weight \< 1000g and gestational age \< 28+0 weeks,
* Received mechanical ventilation within the first 72h of life,
* Undergoing their first planned extubation within the first 6 weeks of life.

Exclusion Criteria:

\- Congenital anomalies and congenital heart disorders.

Where it's running

  • Centre Hospitalier Universitaire Sainte-Justine
    Montreal, Quebec, Canada
    Recruiting
  • McGill University Health Center
    Montreal, Quebec, Canada
    Recruiting

Study contacts

  • Principal investigator: Wissam Shalish, MD, PhD — McGill University Health Center/Montreal Children's hospital
  • Study coordinator: Wissam Shalish, MD, PhD
  • Email: wissam.shalish@mcgill.ca
  • Phone: +1(514) 4124452

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Semaglutide on body composition in adults with type 1 diabetes and overweight/obesity

    This study tests whether weekly semaglutide changes body composition in adults with type 1 diabetes who are overweight or obese, compared with a placebo over 24 weeks.

    Recruiting Phase 2/3 McGill University Health Centre/Research Institute of the McGill University Health Centre · Montreal, Quebec · NCT07891156

  • Adjuvant Hypofractionated Radiotherapy for Endometrial Cancer: Safety, Efficacy, and Quality of Life

    This study tests whether a shorter course of pelvic radiotherapy is safe and effective for women with non-metastatic endometrial cancer, and how it affects their quality of life.

    Recruiting McGill University Health Centre/Research Institute of the McGill University Health Centre · Montreal, Quebec · NCT07871838

  • Can personality traits influence eye side effects from glaucoma meds?

    This study tests whether personality traits are linked to how often or how severely people experience eye side effects from glaucoma medications.

    Recruiting McGill University Health Centre/Research Institute of the McGill University Health Centre · Montreal, Quebec · NCT07739784

  • Wireless MicroPremVitals Button Sensor for the NICU

    This study tests a tiny wireless sensor system to monitor heart rate, oxygen, and temperature in extremely preterm babies in the NICU to see if it works safely without wires.

    Recruiting McGill University Health Centre/Research Institute of the McGill University Health Centre · Montreal, Quebec · NCT07732257

  • Wireless NIRS Sensor Use in the NICU for Monitoring on Neonates

    A wireless NIRS sensor is tested on infants in the NICU to see how well it stays on and how it notes brain signals when used alongside standard wired sensors.

    Recruiting McGill University Health Centre/Research Institute of the McGill University Health Centre · Montreal, Quebec · NCT07732244

  • People with Osteoporosis: See if Walk-BEST Gait Program Helps You Walk Safer

    This pilot study tests whether older adults with osteoporosis can use the Walk-BEST gait training with a wearable sensor to walk more safely and reduce fall risk.

    Recruiting McGill University Health Centre/Research Institute of the McGill University Health Centre · Montreal, Quebec · NCT07621679

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.